The academic affiliation between the Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute fosters educational and research collaborations and stimulates the development of new technologies to radically improve the diagnosis and treatment of human disease.
Both schools bring special strengths to this partnership. Mount Sinai is a leader in biomedical research and patient care, while Rensselaer excels in engineering and computational sciences. The relationship offers cross-disciplinary education that enriches research at all levels and creates new technologies that generate new intellectual property. This collaboration accelerates the pace of innovation and entrepreneurship across the health sciences.
Center for Engineering and Precision Medicine
This long-term partnership has led to the development and launch of the Center for Engineering and Precision Medicine (CEPM), which focuses on research, education, and commercialization. Research efforts emphasize translational science, combining the engineering expertise of Rensselaer with the medical expertise of Mount Sinai to develop medical interventions that enhance patient health. We concentrate on three areas: immunoengineering, neuroengineering, and regenerative and reparative medicine.
In addition, the center has recruited the first cohort of students for the Joint RPI-Mount Sinai PhD in Health Sciences Engineering program that starts in fall 2025. We anticipate developing further educational opportunities, including master’s degrees and certificate programs, as well as a National Institutes of Health NIH T32 Training Program. CEPM Development Labs serve as the translational hub of the center’s research, enabling us to host cutting-edge New York City Startups and commercialize our discoveries in a way that keeps researchers tied to the entire process.
For more information about the PhD program and the Center for Engineering and Precision Medicine, please visit the center's website.